A more recent study investigated the interplay between DNA methylation and genetic background in the DRB1 region and found that MS patients who were carriers of the high risk HLA-DRB1 15*01 allele had significantly lower DNA methylation at HLA-DRB1 compared to those who were not carriers. Here, HLA-DRB1 is linked to myeloid sarcoma.